Emedgene
The company provides an AI-driven software platform for germline variant interpretation and biological data analysis. The technology automates the interpretation of genetic tests to support clinical applications in rare diseases and genetic research. It is integrated into a broader suite of genomic informatics tools used by health organizations and research institutions.
Healthtech
Genomics
Biotechnology
Software
Funding summary
- Total raised
- €5.2M
- Funding rounds
- 1
Investors in Emedgene
Investors on record for Emedgene. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Emedgene?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors